Pharma academic research - Indian patent applications published on 12th February 2016
Every week of thousands of patent applications are published in India. The patent applications filed by the pharma academic research institutes in India go un-noticed.
We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes. For details of these patents, please write back to us at pharmaliterati@gmail.com
Invention
|
Application No
|
Inventors
|
Institute
|
12th February,
2016
|
|||
Directly
compressible DIFRA starch with improved binding, disintegrate and flow
properties
|
201621002062A
|
1)
Naseem Ahmad Charoo
2)
Daud Baraka Abdallah
3)
Aamer Roshan Ali Khatri
4)
Abubakr Suliman Algorashi
|
Not
known
|
5-nitrofuranyl-4-oxo-2-thioxothiazolidin-3-YL
derivatives for the treatment of tuberculosis
|
2436/MUM/2014A
|
1)
Gupta Revathi Arun
|
RKDF
institute of Pharmaceutical Sciences, Indore, Madhya Pradesh.
|
Novel
antiviral combination for treating asian and east central south african
genotypes of chikungunya and dengue virus
|
3266/CHE/2014A
|
1)
Prof. Dr. Rajarajan Swaminathan
2)
Sangeetha Kothandan
|
University
of Madras.
|
Novel
antiviral combination for treating asian and east central south african
genotypes of chikungunya virus and method for producing the same
|
3267/CHE/2014A
|
1)
Prof. Dr. Rajarajan Swaminathan
2)
Sangeetha Kothandan
|
University
of Madras.
|
Novel
compound as an antiviral agent against the asian and east central south
african genotypes of chikungunya and dengue virus
|
3268/CHE/2014A
|
1)
Prof. Dr. Rajarajan Swaminathan
2)
Sangeetha Kothandan
|
University
of Madras.
|
Novel
compound for treating sensitive, isoniazid resistant strains and multi drug
resistant mycobacterium tuberculosis
|
3269/CHE/2014A
|
1)
Prof. Dr. Rajarajan Swaminathan
2)
Dr. Soundhari Chidambaram
|
University
of Madras.
|
Novel
compound for treating sensitive, isoniazid resistant strains and multi drug
resistant mycobacterium tuberculosis
|
3270/CHE/2014A
|
1)
Prof. Dr. Rajarajan Swaminathan
2)
Dr. Soundhari Chidambaram
|
University
of Madras.
|
Delivery
of telmisartan by making formulations containing nanocrystals or disordered
crystals of it and a process without use of alkalanizers or solvents for the
preparation thereof.
|
830/KOL/2014A
|
1)
Jinu Isaac
2)
Animesh Ghosh
3)
Swastika Ganguly
4)
Santanu Kaity
|
Department
of Pharmaceutical Science & Technology, Birla Institute of Technology
(BIT), Ranchi, Jharkhand.
|
Comments
Post a Comment